SOAT1 and vitiligo: Our study first combined network pharmacology, molecular docking, Molecular dynamics simulation, and experimental verification to demonstrate that FHB could significantly reduce the expression of JAK-STAT pathway genes, alleviate inflammation and enhance the secretion of melanogenesis-related factors TYR to promote melanin pigmentation, which may support FHB as an alternative therapy for the treatment of inflammation and vitiligo.